BRCA1 and hemoglobin measurement: A relationship between upregulation of the breast cancer 1 (BRCA1) pathway, which regulates the double-strand DNA HR system, and resistance to doxorubicin in tumors from patients with HB classified in the subgroup C2A, with the worse prognosis and response to chemotherapy, has been found [9].